Please try another search
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles that improve the lives of patients suffering from a multitude of commonly diagnosed conditions. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). Its CTx-1301 and CTx-1302 drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+).
Name | Age | Since | Title |
---|---|---|---|
Brian D. Barash | - | - | Member of Scientific Advisory Board |
Andrew J. Cutler | - | - | Member of Scientific Advisory Board |
John S. Markowitz | - | - | Member of Scientific Advisory Board |
Alice Mao | - | - | Member of Scientific Advisory Board |
Ann Childress | - | - | Member of Scientific Advisory Board |
Sharon B. Wigal | - | - | Member of Scientific Advisory Board |
Peter J. Werth | 84 | 2018 | Director |
Declan Quinn | - | - | Member of Scientific Advisory Board |
Ignacio Herman Valdes | - | - | Member of Scientific Advisory Board |
Dinohra Munoz-Silva | - | - | Member of Scientific Advisory Board |
Jeffrey S. Ervin | 46 | 2024 | Director |
Bryan Jay Lawrence | 58 | 2024 | Director |
Jeffrey Newcorn | - | - | Member of Scientific Advisory Board |
Laurence L. Greenhill | - | - | Member of Scientific Advisory Board |
John A. Roberts | 65 | 2024 | Independent Director |
Shane J. Schaffer | 49 | 2012 | CEO & Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review